Entity Details

Primary name MGAT2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ10469
EntryNameMGAT2_HUMAN
FullNameAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
TaxID9606
Evidenceevidence at protein level
Length447
SequenceStatuscomplete
DateCreated1996-10-01
DateModified2021-06-02

Ontological Relatives

GenesMGAT2

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0005794 Golgi apparatus
GO:0005795 Golgi stack
GO:0006487 protein N-linked glycosylation
GO:0008455 alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
GO:0009312 oligosaccharide biosynthetic process
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0018279 protein N-linked glycosylation via asparagine
GO:0019082 viral protein processing
GO:0030145 manganese ion binding
GO:0030246 carbohydrate binding
GO:0042803 protein homodimerization activity

Subcellular Location

Show/Hide Table
Subcellular Location
Golgi apparatus membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR007754 N-acetylglucosaminyltransferase IIFamilyFamily
IPR029044 Nucleotide-diphospho-sugar transferasesFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
212066 OMIMCongenital disorder of glycosylation 2A (CDG2A)A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. The disease is caused by variants affecting the gene represented in this entry.

Interactions

0 interactions

InteractorPartnerSourcesPublicationsLink